US 8324366
Compositions and methods for delivering RNAI using lipoproteins
granted A61KA61K47/554A61K47/6919
Quick answer
US patent 8324366 (Compositions and methods for delivering RNAI using lipoproteins) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/554, A61K47/6919